Paperpal Prime Logo

TRANSLATIONAL LUNG CANCER RESEARCH : Impact Factor & More

eISSN: 2226-4477pISSN: 2218-6751

Key Metrics

Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on TRANSLATIONAL LUNG CANCER RESEARCH

TRANSLATIONAL LUNG CANCER RESEARCH Journal Specifications

Overview
Publisher AME PUBLISHING COMPANY
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in TRANSLATIONAL LUNG CANCER RESEARCH ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in TRANSLATIONAL LUNG CANCER RESEARCH

The impact of local tumor immune responses on prognosis in resected lung adenocarcinoma.
  • 30 Jun 2026
  • Translational lung cancer research
Lobectomy, segmentectomy, and wedge resection for elderly patients with solid-predominant stage I NSCLC: survival, pulmonary function, and postoperative outcomes.
  • 30 Jun 2026
  • Translational lung cancer research
Development and validation of a dual-attention deep learning prediction model for noninvasive differentiation of pulmonary invasive mucinous adenocarcinoma from inflammatory pulmonary nodules.
  • 30 Jun 2026
  • Translational lung cancer research
End-of-life management and causes of death in ALK-positive non-small cell lung cancer in France: a multicentric analysis.
  • 30 Jun 2026
  • Translational lung cancer research
Assessment of tumor mutation burden based on whole-exome sequencing of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid in advanced non-small cell lung cancer treated with pembrolizumab: a prospective, multicenter, observational study.
  • 30 Jun 2026
  • Translational lung cancer research
Over- and underscreening for lung cancer.
  • 30 Jun 2026
  • Translational lung cancer research
The impact of local tumor immune responses on prognosis in resected lung adenocarcinoma.
  • 30 Jun 2026
  • Translational lung cancer research
Lobectomy, segmentectomy, and wedge resection for elderly patients with solid-predominant stage I NSCLC: survival, pulmonary function, and postoperative outcomes.
  • 30 Jun 2026
  • Translational lung cancer research
Development and validation of a dual-attention deep learning prediction model for noninvasive differentiation of pulmonary invasive mucinous adenocarcinoma from inflammatory pulmonary nodules.
  • 30 Jun 2026
  • Translational lung cancer research
End-of-life management and causes of death in ALK-positive non-small cell lung cancer in France: a multicentric analysis.
  • 30 Jun 2026
  • Translational lung cancer research
Assessment of tumor mutation burden based on whole-exome sequencing of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid in advanced non-small cell lung cancer treated with pembrolizumab: a prospective, multicenter, observational study.
  • 30 Jun 2026
  • Translational lung cancer research
Over- and underscreening for lung cancer.
  • 30 Jun 2026
  • Translational lung cancer research

FAQs on TRANSLATIONAL LUNG CANCER RESEARCH